These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9590243)

  • 1. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
    Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
    J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
    Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
    Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
    Braud VM; Allan DS; Wilson D; McMichael AJ
    Curr Biol; 1998 Jan; 8(1):1-10. PubMed ID: 9427624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines.
    Palmisano GL; Contardi E; Morabito A; Gargaglione V; Ferrara GB; Pistillo MP
    Hum Immunol; 2005 Jan; 66(1):1-12. PubMed ID: 15620456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide.
    Bacik I; Cox JH; Anderson R; Yewdell JW; Bennink JR
    J Immunol; 1994 Jan; 152(2):381-7. PubMed ID: 8283027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-dependent expression of HLA-B7 on antigen processing-deficient T2 cells.
    Smith KD; Lutz CT
    J Immunol; 1996 May; 156(10):3755-64. PubMed ID: 8621911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.
    Lampen MH; Hassan C; Sluijter M; Geluk A; Dijkman K; Tjon JM; de Ru AH; van der Burg SH; van Veelen PA; van Hall T
    Mol Immunol; 2013 Jan; 53(1-2):126-31. PubMed ID: 22898188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
    Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA non-A,B,C class I genes: their structure and expression.
    Heinrichs H; Orr HT
    Immunol Res; 1990; 9(4):265-74. PubMed ID: 2089074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
    Lee N; Malacko AR; Ishitani A; Chen MC; Bajorath J; Marquardt H; Geraghty DE
    Immunity; 1995 Nov; 3(5):591-600. PubMed ID: 7584149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen processing and presentation by human trophoblast-derived cell lines.
    Gobin SJ; Wilson L; Keijsers V; Van den Elsen PJ
    J Immunol; 1997 Apr; 158(8):3587-92. PubMed ID: 9103419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.
    Neisig A; Roelse J; Sijts AJ; Ossendorp F; Feltkamp MC; Kast WM; Melief CJ; Neefjes JJ
    J Immunol; 1995 Feb; 154(3):1273-9. PubMed ID: 7822796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.
    Neisig A; Wubbolts R; Zang X; Melief C; Neefjes J
    J Immunol; 1996 May; 156(9):3196-206. PubMed ID: 8617941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.
    Celik AA; Kraemer T; Huyton T; Blasczyk R; Bade-Döding C
    Immunogenetics; 2016 Jan; 68(1):29-41. PubMed ID: 26552660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.